VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+1.66%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$40.3B
AUM Growth
+$40.3B
(-1.6%)
Cap. Flow
-$673M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
14.49%
Holding
2,585
New
23
Increased
504
Reduced
839
Closed
72
Top Buys
| 1 |
AbbVie
ABBV
|
$304M |
| 2 |
Tapestry
TPR
|
$249M |
| 3 |
Applied Materials
AMAT
|
$190M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
$177M |
| 5 |
Schlumberger
SLB
|
$175M |
Top Sells
| 1 |
JAH
JARDEN CORPORATION
JAH
|
$204M |
| 2 |
Pfizer
PFE
|
$194M |
| 3 |
Nike
NKE
|
$191M |
| 4 |
Intel
INTC
|
$187M |
| 5 |
Cognizant
CTSH
|
$184M |
Sector Composition
| 1 | Technology | 15.28% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $1.22B | 3.01% | 11,148,363 -122,453 | -1% | -$13.3M |
|
2
Microsoft
MSFT
$3.77T
| $825M | 2.05% | 14,939,057 +434,301 | +3% | +$24M |
|
3
Alphabet (Google) Class A
GOOGL
$2.57T
| $585M | 1.45% | 767,413 -70,285 | -8% | -$53.6M |
|
4
Amazon
AMZN
$2.44T
| $564M | 1.4% | 950,154 -119,097 | -11% | -$70.7M |
|
5
Comcast
CMCSA
$125B
| $482M | 1.2% | 7,892,843 +738,287 | +10% | +$45.1M |
|
6
McDonald's
MCD
$224B
| $467M | 1.16% | 3,717,191 -313,550 | -8% | -$39.4M |
|
7
Home Depot
HD
$405B
| $457M | 1.13% | 3,427,057 -1,060,743 | -24% | -$142M |
|
8
UnitedHealth
UNH
$281B
| $454M | 1.13% | 3,521,857 -18,699 | -0.5% | -$2.41M |
|
9
Wells Fargo
WFC
$263B
| $397M | 0.98% | 8,202,098 +209,550 | +3% | +$10.1M |
|
10
PepsiCo
PEP
$204B
| $395M | 0.98% | 3,858,916 -1,422,380 | -27% | -$146M |
|
11
Cisco
CSCO
$274B
| $362M | 0.9% | 12,722,870 +1,038,901 | +9% | +$29.6M |
|
12
Meta Platforms (Facebook)
META
$1.86T
| $354M | 0.88% | 3,101,870 +391,699 | +14% | +$44.7M |
|
|
13
Tapestry
TPR
$21.2B
| $353M | 0.87% | 8,800,126 +6,203,437 | +239% | +$249M |
|
|
14
AbbVie
ABBV
$372B
| $352M | 0.87% | 6,155,253 +5,325,857 | +642% | +$304M |
|
15
Amgen
AMGN
$155B
| $333M | 0.83% | 2,221,532 -3,631 | -0.2% | -$544K |
|
16
Visa
V
$683B
| $333M | 0.83% | 4,351,698 -1,085,607 | -20% | -$83M |
|
17
Gilead Sciences
GILD
$140B
| $331M | 0.82% | 3,608,315 +93,113 | +3% | +$8.55M |
|
18
CVS Health
CVS
$92.8B
| $328M | 0.81% | 3,162,092 -644,336 | -17% | -$66.8M |
|
19
AT&T
T
$209B
| $312M | 0.77% | 7,953,463 -1,037,420 | -12% | -$40.6M |
|
20
Chevron
CVX
$324B
| $308M | 0.76% | 3,226,746 +344,005 | +12% | +$32.8M |
|
21
Merck
MRK
$210B
| $293M | 0.73% | 5,540,079 -2,584,133 | -32% | -$137M |
|
22
Roper Technologies
ROP
$56.6B
| $293M | 0.73% | 1,602,485 +331,754 | +26% | +$60.6M |
|
23
Exxon Mobil
XOM
$487B
| $289M | 0.72% | 3,462,806 -61,983 | -2% | -$5.18M |
|
24
JPMorgan Chase
JPM
$829B
| $282M | 0.7% | 4,760,178 -1,367,560 | -22% | -$81M |
|
25
Bristol-Myers Squibb
BMY
$96B
| $265M | 0.66% | 4,153,833 -2,071,942 | -33% | -$132M |
|